drugset / Trial / NCT07307794
To Evaluate the Adhesion of TK-254RX on Healthy Participants
Phase 1
Recruiting
90 enrolled
Teikoku Seiyaku Co., Ltd.
CRM Biometrics GmbH · collabClinSearch · collabHWI pharma services GmbH · collabSocraMetrics GmbH · collabSocraTec R&D GmbH · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.
Timeline
- Start
- 2026-01-19
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esflurbiprofen | Small molecule | — | Topical |
Indications
No indication recorded.